NovaBay Pharmaceuticals, Inc. (NBY)
2.40
+0.59
(+32.60%)
USD |
NYAM |
Dec 10, 16:00
2.40
0.00 (0.00%)
After-Hours: 16:10
NovaBay Pharmaceuticals EPS Diluted (Quarterly): -0.22 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.333M |
| Revenue (Quarterly) | 0.521M |
| Total Expenses (Quarterly) | 1.854M |
| Enterprise Value | 231.06M |
| Gross Profit Margin (Quarterly) | 8.06% |
| Profit Margin (Quarterly) | -255.9% |
| Earnings Yield | 24.80% |
| Normalized Earnings Yield | 27.99 |